Saratoga Capital Investment Brief
Saratoga Capital Partners is pleased to announce its strategic investment in Orange Nebula, a healthcare technology company focused on modernising pharmacy access through an innovative digital platform connecting healthcare providers, patients and pharmacy services.
The investment represents Saratoga Capital’s continued focus on businesses where technology can improve established processes, create operational efficiencies and provide a platform for scalable growth.
Orange Nebula addresses a specific challenge within healthcare: connecting the prescription process with the pharmacy services required to fulfil it efficiently.
The company’s approach combines healthcare expertise with digital infrastructure to simplify prescription management and improve the post-consultation experience for both healthcare providers and their patients.
A Technology Platform for Pharmacy Access
Orange Nebula has developed a proprietary digital platform designed to connect medical professionals, patients and pharmacy services.
The platform enables patients to receive prescribed medication within 48 hours following consultation with participating healthcare professionals.
A QR-code-enabled workflow simplifies the prescription process and provides a more direct connection between the healthcare provider, patient and pharmacy partner.
The objective is straightforward.
Reduce friction in the prescription process.
For patients, this can make access to prescribed medication more convenient.
For healthcare providers, it can simplify an administrative process that traditionally sits outside the core clinical interaction.
For pharmacy partners, the platform provides an integrated channel through which prescriptions can be managed and fulfilled.
A B2B Healthcare Model
Orange Nebula’s business model is centred on partnerships with healthcare providers, including chiropractic clinics and other medical practices.
Rather than attempting to build a consumer pharmacy business independently, the company is developing a B2B platform that integrates pharmacy services into existing healthcare relationships.
This creates a network effect around the platform.
Healthcare providers gain access to an integrated pharmacy solution.
Patients gain a more streamlined route from consultation to prescription fulfilment.
Pharmacy partners gain access to an organised network of healthcare relationships.
The technology therefore sits between the participants in the healthcare process rather than attempting to replace them.
Addressing an Operational Inefficiency
The investment thesis is based partly on the inefficiency that can arise between a medical consultation and the subsequent fulfilment of a prescription.
The clinical decision may be completed in minutes.
The patient’s access to medication can involve additional administrative steps, communication between different parties and a separate interaction with a pharmacy.
Orange Nebula is designed to simplify that process.
By integrating prescription management into the healthcare provider’s workflow, the platform seeks to reduce unnecessary friction and improve the overall patient experience.
This is a characteristic Saratoga Capital looks for in technology investments: a clearly identifiable operational problem that can potentially be addressed through a scalable digital solution.
Healthcare Expertise and Technology
Orange Nebula is led by Dr. Ali Rafie, a healthcare professional with more than three decades of clinical experience.
That combination of clinical expertise and technology development is important to the company’s proposition.
Healthcare technology businesses must solve two problems simultaneously.
The technology needs to work.
But it also needs to fit the practical realities of healthcare delivery.
A platform designed without a detailed understanding of the clinical environment can struggle to achieve adoption.
Orange Nebula’s model is therefore grounded in the experience of its management team as well as its technology.
An Initial Focus on Specialist Healthcare Markets
The company’s initial commercial focus includes the personal-injury and workers’ compensation sectors.
These markets can involve complex interactions between healthcare providers, patients, insurers, legal representatives and pharmacies.
Prescription fulfilment is one component within that broader process.
By providing a technology-enabled pharmacy solution, Orange Nebula is seeking to simplify one part of the administrative and operational chain.
The opportunity is therefore not simply to digitise an existing process.
It is to integrate that process more effectively into the wider healthcare ecosystem.
The Investment Thesis
Saratoga Capital identified several characteristics supporting the investment opportunity.
The first is the company’s proprietary technology platform and its focus on a clearly defined operational problem.
The second is its B2B model, which provides a framework for developing relationships with healthcare providers and pharmacy partners.
The third is the experience of the management team and its understanding of healthcare delivery.
The fourth is the potential for the platform to expand across additional healthcare providers and markets.
The fifth is the broader shift toward technology-enabled healthcare services.
Together, these characteristics provide the foundation for Saratoga Capital’s investment thesis.
Scaling the Platform
The next stage of Orange Nebula’s development is focused on expanding the company’s network and strengthening its technology platform.
Saratoga Capital’s investment is intended to provide both capital and operational support for that process.
Key priorities include expanding relationships with healthcare providers, extending the platform across additional markets, improving product functionality and user experience, and strengthening commercial and business-development capabilities.
The company also intends to develop strategic partnerships within the broader healthcare ecosystem.
This is important because the value of a B2B platform is closely connected to the strength and scale of the network around it.
Building the Infrastructure for Growth
Technology businesses can scale quickly, but sustainable growth requires more than software.
As Orange Nebula expands, the organisation will need appropriate governance, compliance procedures, commercial systems and operational infrastructure.
Healthcare is also a highly regulated environment.
The technology therefore needs to be supported by appropriate processes for managing data, relationships and regulatory obligations.
Saratoga Capital’s role includes supporting the development of that infrastructure alongside the company’s commercial expansion.
The objective is to build a business capable of scaling responsibly rather than pursuing growth without the organisational foundation required to sustain it.
The Digital Healthcare Opportunity
The investment reflects a broader transformation taking place across healthcare.
Technology is increasingly being used to connect patients, healthcare professionals and service providers.
Telemedicine, digital records, electronic prescriptions and other technology-enabled services are changing the way healthcare is delivered and managed.
Orange Nebula operates within that broader transition.
Its proposition is focused on a specific part of the healthcare journey rather than attempting to build a complete healthcare platform.
That focus can be an advantage.
By concentrating on prescription fulfilment and pharmacy access, the company can develop specialised technology around a clearly defined problem.
From Technology to Operating Platform
For Saratoga Capital, the longer-term opportunity lies in developing Orange Nebula from a technology product into a broader operating platform.
The platform’s value can increase as more healthcare providers participate, additional pharmacy relationships are established and the technology becomes integrated more deeply into the workflows of participating organisations.
That creates the possibility of a scalable B2B model.
Growth can come not only from adding individual customers, but from expanding the network surrounding the platform.
The objective is therefore to build an infrastructure business rather than simply a software product.
Saratoga Capital’s Role
Saratoga Capital’s investment is intended to accelerate Orange Nebula’s next phase of development.
Capital will support technology investment, commercial expansion and organisational development.
The firm will also work with management on strategic partnerships, governance and the infrastructure required to support growth.
This reflects Saratoga Capital’s broader approach to private equity investing.
The objective is not simply to provide capital to an existing business.
It is to work alongside management to identify the capabilities required for the next stage and help build them.
Looking Ahead
Orange Nebula represents an investment in the intersection of healthcare and technology.
The company has identified a specific inefficiency within the prescription process and developed a digital platform designed to connect healthcare providers, patients and pharmacy services more effectively.
The immediate opportunity is to expand the provider network, strengthen the technology and develop the commercial infrastructure required for further growth.
Over the longer term, the ambition is to establish Orange Nebula as a scalable healthcare technology platform supporting more efficient pharmacy access.
For Saratoga Capital, the investment illustrates the attraction of businesses that combine specialist industry knowledge with technology capable of addressing identifiable operational problems.
The opportunity is to take an established healthcare process, improve the way its participants interact, and build a scalable business around that improvement.
Investor Note
This investment brief is provided for general information and describes Saratoga Capital’s investment perspective. It is not an offer or solicitation to purchase securities or an investment recommendation. Past or anticipated business performance should not be interpreted as a guarantee of future results.
About Saratoga Capital
Founded in 2008, Saratoga Capital Partners is a private equity and alternative asset management firm with a strong foundation in advisory and capital markets. Today, we develop and manage differentiated investment solutions, partnering with entrepreneurs, management teams, and investors to unlock opportunity, create enduring value, and deliver attractive long-term returns.